TABLE OF CONTENTS
Volume 30, Issue 9 (September 2005)
Original Articles
Preclinical Research
Effects of Altered Amygdalar Neuropeptide Y Expression on Anxiety-Related Behaviors FREE
Stefany D Primeaux, Steven P Wilson, Michael C Cusick, David A York and Marlene A Wilson
Neuropsychopharmacology 30: 1589-1597; advance online publication, March 16, 2005; doi:10.1038/sj.npp.1300705
ER
-Selective Estrogen Receptor Modulators Produce Antianxiety Behavior when Administered Systemically to Ovariectomized Rats FREE
Alicia A Walf and Cheryl A Frye
Neuropsychopharmacology 30: 1598-1609; advance online publication, March 30, 2005; doi:10.1038/sj.npp.1300713
Chronic Low-Dose Corticosterone Supplementation Enhances Acquired Epileptogenesis in the Rat Amygdala Kindling Model of TLE FREE
Taufik R Taher, Michael Salzberg, Margaret J Morris, Sandra Rees and Terence J O'Brien
Neuropsychopharmacology 30: 1610-1616; advance online publication, March 16, 2005; doi:10.1038/sj.npp.1300709
Gestational Dexamethasone Treatment Elicits Sex-Dependent Alterations in Locomotor Activity, Reward-Based Memory and Hippocampal Cholinergic Function in Adolescent and Adult Rats FREE
Marisa L Kreider, Edward D Levin, Frederic J Seidler and Theodore A Slotkin
Neuropsychopharmacology 30: 1617-1623; advance online publication, April 6, 2005; doi:10.1038/sj.npp.1300716
Effect of Increased Serotonin Levels on [18F]MPPF Binding in Rat Brain: Fenfluramine vs the Combination of Citalopram and Ketanserin FREE
Joanna I Udo de Haes, Thomas I F H Cremers, Fokko-J Bosker, Folkert Postema, Theodora D Tiemersma-Wegman and Johan A den Boer
Neuropsychopharmacology 30: 1624-1631; advance online publication, April 13, 2005; doi:10.1038/sj.npp.1300721
The RGSZ2 Protein Exists in a Complex with 
-Opioid Receptors and Regulates the Desensitizing Capacity of Gz Proteins FREE
Javier Garzón, María Rodríguez-Muñoz, Almudena López-Fando and Pilar Sánchez-Blázquez
Neuropsychopharmacology 30: 1632-1648; advance online publication, April 13, 2005; doi:10.1038/sj.npp.1300726
The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys FREE
Karl-Anton Dorph-Petersen, Joseph N Pierri, James M Perel, Zhuoxin Sun, Allan R Sampson and David A Lewis
Neuropsychopharmacology 30: 1649-1661; advance online publication, March 9, 2005; doi:10.1038/sj.npp.1300710
Prior Multiple Ethanol Withdrawals Enhance Stress-Induced Anxiety-Like Behavior: Inhibition by CRF1- and Benzodiazepine-Receptor Antagonists and a 5-HT1a-Receptor Agonist FREE
George R Breese, David H Overstreet, Darin J Knapp and Montserrat Navarro
Neuropsychopharmacology 30: 1662-1669; advance online publication, February 23, 2005; doi:10.1038/sj.npp.1300706
Lack of CB1 Cannabinoid Receptor Impairs Cocaine Self-Administration FREE
Guadalupe Soria, Victoria Mendizábal, Clara Touriño, Patricia Robledo, Catherine Ledent, Marc Parmentier, Rafael Maldonado and Olga Valverde
Neuropsychopharmacology 30: 1670-1680; advance online publication, March 2, 2005; doi:10.1038/sj.npp.1300707
Rats Maintained Chronically on Buprenorphine Show Reduced Heroin and Cocaine Seeking in Tests of Extinction and Drug-Induced Reinstatement FREE
Robert E Sorge, Heshmat Rajabi and Jane Stewart
Neuropsychopharmacology 30: 1681-1692; advance online publication, March 30, 2005; doi:10.1038/sj.npp.1300712
Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex FREE
Paul J Gresch, Randy L Smith, Robert J Barrett and Elaine Sanders-Bush
Neuropsychopharmacology 30: 1693-1702; advance online publication, March 9, 2005; doi:10.1038/sj.npp.1300711
Clinical Research
Association of Multiple DRD2 Polymorphisms with Anorexia Nervosa FREE
Andrew W Bergen, Meredith Yeager, Robert A Welch, Kashif Haque, J Kelly Ganjei, Marianne B M van den Bree, Chiara Mazzanti, Irma Nardi, Manfred M Fichter, Katherine A Halmi, Allan S Kaplan, Michael Strober, Janet Treasure, D Blake Woodside, Cynthia M Bulik, Silviu-Alin Bacanu, Bernie Devlin, Wade H Berrettini, David Goldman and Walter H Kaye
Neuropsychopharmacology 30: 1703-1710; advance online publication, May 25, 2005; doi:10.1038/sj.npp.1300719
Cluster B Personality Disorders are Associated with Allelic Variation of Monoamine Oxidase A Activity FREE
Christian P Jacob, Johannes Müller, Michael Schmidt, Katrin Hohenberger, Lise Gutknecht, Andreas Reif, Armin Schmidtke, Rainald Mössner and Klaus Peter Lesch
Neuropsychopharmacology 30: 1711-1718; advance online publication, May 4, 2005; doi:10.1038/sj.npp.1300737
Association Study of a Monoamine Oxidase A Gene Promoter Polymorphism with Major Depressive Disorder and Antidepressant Response FREE
Younger W-Y Yu, Shih-Jen Tsai, Chen-Jee Hong, Tai-Jui Chen, Ming-Chao Chen and Chih-Wei Yang
Neuropsychopharmacology 30: 1719-1723; advance online publication, June 1, 2005; doi:10.1038/sj.npp.1300785
The Effect of Citalopram Pretreatment on Neuronal Responses to Neuropsychological Tasks in Normal Volunteers: An fMRI Study FREE
Cristina M Del-Ben, J F William Deakin, Shane Mckie, Nicola A Delvai, Steve R Williams, Rebecca Elliott, Mairead Dolan and Ian M Anderson
Neuropsychopharmacology 30: 1724-1734; advance online publication, April 13, 2005; doi:10.1038/sj.npp.1300728
Glutamatergic Dysfunction in OCD FREE
Kaushik Chakrabarty, Sagnik Bhattacharyya, Rita Christopher and Sumant Khanna
Neuropsychopharmacology 30: 1735-1740; advance online publication, April 20, 2005; doi:10.1038/sj.npp.1300733
Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB FREE
Una D McCann, Zsolt Szabo, Esen Seckin, Peter Rosenblatt, William B Mathews, Hayden T Ravert, Robert F Dannals and George A Ricaurte
Neuropsychopharmacology 30: 1741-1750; advance online publication, April 20, 2005; doi:10.1038/sj.npp.1300736
Effects of Low- and High-Nicotine Cigarette Smoking on Mood States and the HPA Axis in Men FREE
Jack H Mendelson, Michelle B Sholar, Nathalie Goletiani, Arthur J Siegel and Nancy K Mello
Neuropsychopharmacology 30: 1751-1763; advance online publication, May 4, 2005; doi:10.1038/sj.npp.1300753
Obituaries
Dr Julius Axelrod, 1912–2004 FREE
Solomon H Snyder
Neuropsychopharmacology 30: 1764-1766; doi:10.1038/sj.npp.1300799
Ernest B Sigg, 1924–2004 FREE
W Dale Horst, John A Moyer, Walter Schlosser and Fridolin Sulser
Neuropsychopharmacology 30: 1767-1768; doi:10.1038/sj.npp.1300801
Correspondence
Plasma Leptin and Antipsychotic-Induced Body Weight Gain FREE
Palmiero Monteleone, Michele Fabrazzo and Mario Maj
Neuropsychopharmacology 30: 1769; doi:10.1038/sj.npp.1300792
Correspondence
Reply: Plasma Leptin and Antipsychotic-Induced Body Weight Gain FREE
Dan Haupt and John Newcomer
Neuropsychopharmacology 30: 1770-1771; doi:10.1038/sj.npp.1300793
